Drug Trial Radar · NCT05263583
Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14
Actual
Start
Dec 3, 2022
Primary completion
Feb 12, 2025
Study completion Feb 12, 2025
Sponsor
- Lead sponsor
- Cothera Bioscience, IncIndustry
- Sponsor type
- Industry
- First posted
- Mar 2, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center Phase 2 study to determine the safety and efficacy of sepantronium bromide (SepB) in adult patients with relapsed or refractory high-grade B-cell lymphoma
Conditions
- High-grade B-cell Lymphoma
- Burkitt Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphatic Diseases
- Lymphoma, High-Grade
- C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma
- C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma
- C-Myc Gene Rearrangement
Interventions
Sepantronium BromideDrug
continuous intravenous infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerability and recommended Phase 2 dose of sepantronium bromideTime frame: From time of signing informed consent through 30 days after the last dose of study drug, an average of 6 months
Locations
11 sites in 2 countries. Site status is shown where the registry gives one.
Beijing Cancer Hospital
Beijing, China
Sun Yat-sen University Cancer Center
Guangzhou, China
Henan Cancer Hospital
Henan, China
Shanghai East Hospital
Pudong, China
Tianjin Cancer Hospital
Tianjin, China
Tongji Hospital
Wuhan, China
Dong-A University Hospital
Busan, South Korea
Inje University Haeundae Paik hospital
Busan, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Seoul St.Mary's Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.